Mayo Clinic cancer researchers receive funding from 2019 Eagles Telethon
Mayo Clinic researchers received funding from the 2019 Eagles Cancer Telethon in Rochester, Minnesota. The $580,000 raised will fund four fellowship awards and 10 pilot program awards. The Mayo Clinic Center for Biomedical Discovery provided an additional $50,000 to support two fellowship awards.
The 5th District Eagles Cancer Telethon is the longest locally run telethon in the United States, dating back to 1954, making 2019 its 65th year. The nonprofit organization has the longest record of continuous philanthropy for a philanthropic partner at Mayo Clinic. The Eagles Cancer Telethon is a 20-hour event in January on KTTC-TV that showcases more than 100 entertainment acts from southeast Minnesota, northern Iowa and western Wisconsin.
2019 fellowship awardees and projects
*Li Ding, Ph.D. (ONCL ’16), senior research fellow, Oncology Research, Mayo Clinic in Rochester, “GSK-3beta Promotes Oncogenic Kras-driven Pancreatic Cancer Development through AQP5”
Asghar Rezaei, Ph.D. (PHYS ’17), senior research fellow, Department of Physiology and Biomedical Engineering, Mayo Clinic in Rochester, “A Patient-specific QCT-based Technique to Assess the Effect of Lytic Lesion Size and Location on Fracture Risk in Metastatic Spines”
David Routman, M.D. (RADO ’20), resident, Department of Radiation Oncology, Mayo Clinic in Rochester, “Quantification of Circulating Tumor DNA in HPV-associated Malignancy”
*Debiao Zhao, Ph.D. (BIOC ’16), research fellow, Department of Biochemistry and Molecular Biology, Mayo Clinic in Rochester, “Probing the Chromatin Recruitment Mechanisms of BRCA1/RAP80 and RAD18 in DNA Repair with Implications for Cancer Therapy”
*Receiving support from Mayo Clinic Center for Biomedical Discovery
2019 pilot program awardees and projects
Lauren Bangerter, Ph.D. (HSR ’19), research associate, Center for the Science of Health Care Delivery, Mayo Clinic in Rochester, “Technology-enabled Intervention for Caregivers of Hematopoietic Stem Cell Transplant Recipients”
Santanu Bhattacharya, Ph.D. (BIOC ’13), associate consultant I, Department of Biochemistry and Molecular Biology, Mayo Clinic in Florida, “Targeted Nanotheranostic for Pancreatic Ductal Adenocarcinoma”
Janet Denbeigh, Ph.D. (OR ’15), research associate, Department of Radiation Oncology, Mayo Clinic in Rochester, “Proton Induced Myelopathy: Quantifying the Radiobiological Effect in Spinal Cords”
Mi Hyeon Jang, Ph.D. (NS ’12), senior associate consultant I, Department of Neurologic Surgery, Mayo Clinic in Rochester; and Anthony Windebank, M.D. (N ’82), consultant, Department of Neurology, Mayo Clinic in Rochester; “Targeting COX-2 as a Novel Therapy for Chemobrain”
Karishma Rajani, Ph.D. (MMED ’16), research associate, Neurologic Research, Mayo Clinic in Rochester, “Impact of senescence on glioblastoma microenvironment”
Satomi Shiraishi, Ph.D. (RADP ’18), senior associate consultant, Department of Radiation Oncology, Mayo Clinic in Rochester; and Chris Beltran, Ph.D. (RADP ’06), consultant, Department of Radiation Oncology, Mayo Clinic in Rochester; “Radiotherapy Dose and Toxicities: Is There a Specific Part of an Organ that Correlates with Greater Toxicity or Decrements in Quality of Life?”
Principal investigator: Jie Sun, Ph.D. (THDCC ’16), Pulmonary and Critical Care Medicine/Immunology
Zhiquan Wang, Ph.D. (BIOC ’16), research associate, Department of Biochemistry and Molecular Biology, Mayo Clinic in Rochester, “Chromatin Assembly Factor 1 Suppresses Epigenetic Reprogramming toward Drug Resistance”
Sandeep Pagali, M.D. (GERI '14)
"Prospective Validation of a 'Mayo Delirium Prediction' Tool"
Division of Hospital Internal Medicine, Department of Medicine
Assistant professor of medicine
Mayo Clinic in Rochester